Literature DB >> 20613748

RAF translocations expand cancer targets.

Martin McMahon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20613748      PMCID： PMC4263025          DOI： 10.1038/nm0710-749

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

1.  Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.

Authors:  Scott A Tomlins; Bharathi Laxman; Saravana M Dhanasekaran; Beth E Helgeson; Xuhong Cao; David S Morris; Anjana Menon; Xiaojun Jing; Qi Cao; Bo Han; Jindan Yu; Lei Wang; James E Montie; Mark A Rubin; Kenneth J Pienta; Diane Roulston; Rajal B Shah; Sooryanarayana Varambally; Rohit Mehra; Arul M Chinnaiyan
Journal:  Nature       Date:  2007-08-02       Impact factor: 49.962

Review 2.  The RAF proteins take centre stage.

Authors:  Claudia Wellbrock; Maria Karasarides; Richard Marais
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

3.  BRAF mutation predicts sensitivity to MEK inhibition.

Authors:  David B Solit; Levi A Garraway; Christine A Pratilas; Ayana Sawai; Gad Getz; Andrea Basso; Qing Ye; Jose M Lobo; Yuhong She; Iman Osman; Todd R Golub; Judith Sebolt-Leopold; William R Sellers; Neal Rosen
Journal:  Nature       Date:  2005-11-06       Impact factor: 49.962

4.  A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors.

Authors:  David Dankort; Elena Filenova; Manuel Collado; Manuel Serrano; Kirk Jones; Martin McMahon
Journal:  Genes Dev       Date:  2007-02-13       Impact factor: 11.361

5.  Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.

Authors:  D T W Jones; S Kocialkowski; L Liu; D M Pearson; K Ichimura; V P Collins
Journal:  Oncogene       Date:  2009-04-13       Impact factor: 9.867

6.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

7.  Raf-1 protein kinase is required for growth of induced NIH/3T3 cells.

Authors:  W Kolch; G Heidecker; P Lloyd; U R Rapp
Journal:  Nature       Date:  1991-01-31       Impact factor: 49.962

8.  Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

Authors:  David Dankort; David P Curley; Robert A Cartlidge; Betsy Nelson; Anthony N Karnezis; William E Damsky; Mingjian J You; Ronald A DePinho; Martin McMahon; Marcus Bosenberg
Journal:  Nat Genet       Date:  2009-03-12       Impact factor: 38.330

9.  Profiling critical cancer gene mutations in clinical tumor samples.

Authors:  Laura E MacConaill; Catarina D Campbell; Sarah M Kehoe; Adam J Bass; Charles Hatton; Lili Niu; Matt Davis; Keluo Yao; Megan Hanna; Chandrani Mondal; Lauren Luongo; Caroline M Emery; Alissa C Baker; Juliet Philips; Deborah J Goff; Michelangelo Fiorentino; Mark A Rubin; Kornelia Polyak; Jennifer Chan; Yuexiang Wang; Jonathan A Fletcher; Sandro Santagata; Gianni Corso; Franco Roviello; Ramesh Shivdasani; Mark W Kieran; Keith L Ligon; Charles D Stiles; William C Hahn; Matthew L Meyerson; Levi A Garraway
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

10.  BRAF activation initiates but does not maintain invasive prostate adenocarcinoma.

Authors:  Joseph H Jeong; Zhenxiong Wang; Alexander S Guimaraes; Xuesong Ouyang; Jose L Figueiredo; Zhihu Ding; Shan Jiang; Isil Guney; Gyeong Hoon Kang; Eyoung Shin; William C Hahn; Massimo F Loda; Cory Abate-Shen; Ralph Weissleder; Lynda Chin
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240
View more
  2 in total

1.  Elimination of B-RAF in oncogenic C-RAF-expressing alveolar epithelial type II cells reduces MAPK signal intensity and lung tumor growth.

Authors:  Emanuele Zanucco; Nefertiti El-Nikhely; Rudolf Götz; Katharina Weidmann; Verena Pfeiffer; Rajkumar Savai; Werner Seeger; Axel Ullrich; Ulf R Rapp
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

2.  Constructing an integrated genetic and epigenetic cellular network for whole cellular mechanism using high-throughput next-generation sequencing data.

Authors:  Bor-Sen Chen; Cheng-Wei Li
Journal:  BMC Syst Biol       Date:  2016-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.